Home A country-specific COVID-19 model
Article Publicly Available

A country-specific COVID-19 model

  • Gunter Meissner and Hong Sherwin EMAIL logo
Published/Copyright: May 12, 2023
Become an author with De Gruyter Brill

Abstract

Objectives

To dynamically measure COVID-19 transmissibility consistently normalized by population size in each country.

Methods

A reduced-form model enhanced from the classical SIR is proposed to stochastically represent the Reproduction Number and Mortality Rate, directly measuring the combined effects of viral evolution and population behavioral response functions.

Results

Evidences are shown that this e(hanced)-SIR model has the power to fit country-specific empirical data, produce interpretable model parameters to be used for generating probabilistic scenarios adapted to the still unfolding pandemic.

Conclusions

Stochastic processes embedded within compartmental epidemiological models can produce measurables and actionable information for surveillance and planning purposes.

The art of model building is rather subtle; the model should be simple enough to be investigated analytically and flexible enough to reproduce the essential properties of the systems we want to study.

-Giorgio Parisi in “Statistical Field Theory”, p. 22

Model motivation

The novel coronavirus (COVID-19) is a highly contagious and deadly airborne disease. It has claimed millions of lives worldwide since 2020, caused untold economic damages in every country, and is considered as the worst global public health crisis since the Spanish Flu. While each pandemic is inextricably characterized by the virus lineage and pathophysiology, COVID-19 is uniquely marked not only by the significant roles played by public and private mitigation strategies, accelerated developments in vaccination and therapeutics, but also the prevalent social and political beliefs in each country.

The challenge to cast all the causes and effects in a mathematically coherent framework is formidable. It is widely recognized that a credible pandemic model is one that captures the virological heuristics, that reflects the heterogeneity of immunity in a given population, and that describes and interprets empirical data with a demonstrable capability to forecast. Additional properties attractive to modelers encompass robustness and adaptability when applied to different geographies and over time, balanced between sufficient complexity and efficient model calibration.

The classical Susceptible-Infectious-Removed (SIR) compartmental framework pioneered by Kermack and McKendrick (1927) has been a foundational model of choice for communicable diseases. It provides a formulation with which the disease transmission mechanism is expressed in a mathematical form. It has been widely used for evaluation, prediction and infection prevention purposes. Extensive applications of SIR are found in the literature for chickenpox (Giraldo and Palacio 2008), measles (Bjørnstad, Finkenstädt, and Grenfell 2002) and MERS (Saleh et al. 2017), as discussed in Brauer (2005). Propelled by advanced computing and biomedical technology, numerous extensions of SIR made by creating additional compartments augmented with testable features have led to significant progress in the science of epidemiology, contributed to a richer and broader understanding across behavioral and demographical boundaries.

Specifically, at time t, the SIR model places the population of interest into one of three non-intersecting compartments, namely:

Under the construct of SIR, S(t) represents the population who are at risk of becoming infected, I(t) signifies the source and prevalence of the pathogen in circulation, and R(t) measures the population immune to the infection, no longer contagious, both healed or deceased are counted (Table 1).

Table 1:

Epidemiological compartments under SIR model.

S(t) Susceptible, the number of healthy individuals never infected
I(t) Infected, the number of contagious people, symptomatic or not
R(t) Removed, the number of people whose infectious status resolved

The compartmental transmission mechanism described by SIR is diagrammed in Figure 1, with the model parameters defined in Table 2:

The SIR model is constructed as a system of 3-dimensional Ordinary Differential Equations (ODE), with the core discrete-time expression by Equation (1):

Figure 1: 
Epidemiological flow of a pandemic under SIR.
Figure 1:

Epidemiological flow of a pandemic under SIR.

Table 2:

SIR model parameter definition.

N Population size, assumed constant
β Transmission rate (new infections by one infected individual), per unit time
γ Removal rate (of infection resolving for an individual), per unit time

The implicit assumptions made by SIR, as discussed by Brauer (2005), are threefold: (1) an average member of the population makes contact sufficient to transmit infection to β others per unit time; (2) the infected leave the infective class at a rate of γ per unit time, equivalent to an average of infection duration of 1 γ in units of time; (3) there is no entry into or departure from the population, except possibly through death from the disease. A crucial feature shared by the types of pathogens suitable of SIR modeling, as pointed out by Blackwood and Childs (2018), is that the recovered cohort is awarded with life-long immunity.

A non-linear numeric solution of this closed ODE system can be found once the parameters and the initial conditions are known. The world governed by SIR is the one in which the infected population I(t) increases precipitously in an outbreak, then reaches a plateau and eventually decreases at a much slower speed, as the immunity builds and the susceptible population S(t) is being depleted. By design, the SIR model is a self-regulating autonomous system as the drift terms ∆S(t) + ∆I(t) +R(t) are netted to zero intrinsically at all times. While SIR is capable of tracking an endemic from the outset to reaching its finality, the inter-compartment transitions are however deterministic, with the evolution in I(t) features a single peak over the entirety of an epidemic lifecycle.

When applied to COVID-19 pandemic, these well-recognized SIR properties are found to be unrealistic and counterfactual, as several peaks and valleys have already been chronicled since 2020 worldwide. Attempts in fitting empirical data to the basic SIR model only lead to poor parameter estimates, offering no temporal or comparative value for surveillance purpose, and certainly an unlikely candidate for forecasting. The dynamism and realism required by the natural phenomena in COVID-19 pandemic give rise to the proposed stochastic model, allowing a probabilistic approach to describe the variability in the infectivity, resolution and fatality through time and across a variety of demographics.

On a consistent basis, available COVID-19 pandemic data is limited to the confirmed total (cumulative) as well as new cases of Infection and Death at a daily interval. Essentially we are left with all S(t), I(t), R(t) three quantities unknown and in need of a model estimation. It should be remarked that the fatality counts, for individuals deceased from infection, is known empirically although not present in Equation (1) as a standalone compartment.

In the cannon of epidemiological study, the Basic Reproduction Number represents the number of secondary infections that will be produced by a single initially infected case in a population of susceptible individuals. Put more precisely, it is a ratio between new infection cases and removed cases within a given time interval. In a SIR setting, the Basic Reproduction Number, represented by the symbol ρ hence after,[1] is defined as:

(2) ρ = β γ

In practice, the Basic Reproduction Number is often viewed as a precursor – signaling the degree to which the virus replicates in a population and urgent medical care is needed near-term. When ρ > 1, it signifies the virus infects individuals more rapidly than the number of individuals resolving their infection status, thus the total infection and death case counts are expected to both rise as a result. Conversely, when ρ < 1, the infected population is expected to decline in numbers along with the follow-on deaths. For individuals, medical professionals as well as public health officials, assuming ρ a constant and knowable only ex-post is of little value, even if calibrated from empirical data averaging over a lengthy period of time. Instead, allowing the Basic Reproduction Number to be instantaneous and vary over time as a state variable, is not only preferable but mandatory in order to be deployable in real-time.

The Mortality rate from COVID-19 is of the utmost importance both medically and economically, as discussed in Atkeson, Kopecky, and Zha (2020). Judged by the clinical information and evidence gathered across countries, the determinants for fatality are thought to range from patients’ age and underlying medical conditions, to hospital locality and the availabilities of ventilators and ICU beds, not to mention the great variety of COVID-19 variants. A time-varying dynamic Mortality Rate process, replacing the static or deterministic projection, is a critical feature in our proposal.

By modeling the infection reproduction and fatality rate as random processes, we should be able to achieve our dual-objectives: (1) synchronized monitoring of the disease transmissibility and its virology, critical to medical treatments and developments of therapeutics; (2) continuously evaluating the intervention effects from social and medical counter measures. This information is instantly distributable and consumable to the general public, useful for regulating self-protective behavior, and forming effective and risk-based social distancing measures with respect to remote working, home schooling, in-store dining, or safe transportation.

The remainder of the paper is organized as follows: In Section 2 we propose the eSIR model and discuss the epidemiological and model parameters in a structured setting. In Section 3 we describe the operationalized method for a general country-specific model calibration. Section 4 illustrates the procedures used in treating the raw empirical data and presents the main results accompanied by our observations and comments. In Section 5 we demonstrate the usefulness of the stochastic modeling choice by conducting historical simulation and forecasting. Section 6 concludes and discusses future research ideas.

The proposed e(nhanced)-SIRD model

Making use of a set of Stochastic Differential Equations (SDE) should lead to a probabilistic framework better suited for modeling COVID-19 and its intermittent transmissibility. Largely inspired by Perla et al. (2021) and Atkeson, Kopecky, and Zha (2020), we show that our proposed methodology admits a significant model improvement in reproducing empirical data and forecasting, without compromising the expected transparency and interpretability associated with the classical SIR model.

The 2-factor eSIRD model hereby proposed extends the deterministic structural SIR framework by modifying the Basic Reproduction Number ρ as a time-varying random variable ρ(t) which is referred to as the Reproduction Number, and by adding the fatality compartment D(t) formally which is jointly determined by the size of the infected population I(t) and another random factor – the case Mortality Rate m(t). In summary, the epidemiological schema ascribed by our eSIR model is presented in Figure 2.

Figure 2: 
Epidemiological flow of a pandemic under eSIR.
Figure 2:

Epidemiological flow of a pandemic under eSIR.

Where all the state variables and associated model parameters are defined collectively in Table 3 for completeness:

Table 3:

Definitions of eSIR model variables and parameters.

S(t) Susceptibles, containing healthy individuals never infected
I (t) Infectious, irrespective of being symptomatic or asymptomatic
R(t) Recovered, healed and no longer contagious
D (t) Deceased from infection
γ Removal rate from I(t), per unit time, into R(t) or D(t)
ρ(t) Reproduction number (random) defined by Equation (2)
m(t) Mortality rate (random) per unit time

It should be noted that, with the introduction of D(t), the new definition of compartment R(t) is narrowed to contain the recovered individuals only, modified from Table 2 whereas the removed compartment hosts both the recovered and the deceased. It should also be highlighted that this group does not include people with vaccine-induced immunity. Likewise, I(t) group contains only the people who are contagious and actively shedding virus, but not caused by vaccinations. The resolution rate γ, however, remains unchanged from Table 2, a constant parameter representing the outflow rate from the infected I(t) compartment irrespective of the receiving compartment being recovered R(t) or deceased D(t).

The flowchart of Figure 2 prescribes and delineates the stages of infection in a given population: individuals in the susceptible compartment, S(t), are first infected and moved into the infected individuals (tested positive) compartment I(t), at a rate of ρ t γ . Subsequently, the infected individuals resolve their status, at a rate of γ, either by death from COVID infection with a net rate of m(t)γ and moved into the fatality compartment D(t), or by recovering with a healing rate of 1 m t γ and moved into the recovered compartment R(t), in each time step.

Ostensibly the population in the three compartments of interest, namely S(t), R(t) and D(t), experiences only single directional (in or out) flows, while the dynamic of the Infected compartment, I(t), is in-fact multi-directional, increasing from new infections out from S(t) and reducing to R(t) or D(t) concurrently. Same as with SIR, since the existence of COVID-19 is relatively short, the assumption of a closed demography is therefore justified, i.e. the natural births and deaths unrelated to the pandemic are not considered.

Finally, with variables and parameters defined in Table 3, we proceed to write the proposed eSIR model formally as 2 sets of inter-connected differential systems as Equations (3) and (4):

where ρ(t) denotes the instantaneous Reproduction Number and m(t) the instantaneous case Mortality Rate. Furthermore, they are each assumed to evolve following a well-known CIR stochastic process per (Cox, Ingersoll, and Ross 1985):

(4) d ρ t = κ ρ ρ ̄ ρ t d t + σ ρ ρ t d W ρ t d m t = κ m m ̄ m t d t + σ m m t d W m t

The CIR parameters required by Equation (4) are:

CIR model was introduced first in a seminal paper CIR (1985) and has been prominently applied in the field of financial mathematics, in particular for modeling interest rates. Stationary, positivity, local volatility and mean-reverting are the most distinguishing features when a CIR process is characterized (Table 4). This can be seen in our proposal where the diffusion coefficients are specified as σ ρ ρ t , σ m m t corresponding to strictly positive valuations of { ρ t , m t , as the infection reproduction and death rate shall never be negative in epidemiological terms. The long term mean, i.e. the latent asymptotic value ρ ̄ = lim t ρ ( t ) or m ̄ = lim t m ( t ) , has a well-understood role in a mean-reversion process and gives a well-defined asymptotic distribution. This is once again consistent with the repeated outbreaks already observed for COVID-19, and the biostatistical verity that is, with sufficient time, all pandemics do subside and eventually extinct.

Table 4:

Parameter definitions of Equation (4).

κρ, κm Mean reversion rate of ρ(t), m(t)
σρ, σm Diffusion scaling factors of ρ(t), m(t)
ρ ̄ , m ̄ Long term (asymptotic) mean of ρ(t), m(t)

The sources of risk or randomness that generate this 2-factor stochastic system in Equation (4) are the Brownian motions {Wρ(t), Wm(t)} drawn from independent[2] normal distributions N(0,dt) with zero mean and a dt-sized variance. In our approach, these native innovations are first transmitted through the state variables { ρ t , m t and then propagated to all four SIRD compartments governed by Equation (3), with the case counts of new or cumulative infections and deaths as the ultimate observables.

It is worth noting that reinfections from COVID-19, while not common, do occur. Repeat cases have been sporadically observed and reported, as the gains in herd immunity from natural infection or inoculation are partially offset by the countervailing factors such as low vaccine rates and viral mutations in a continuum. Without a clear clinical definition in reinfection, without a universal contact tracing and persistent screening test targeting each variant, an epidemiological model is unable to accurately measure and discern these effects judiciously. Absent of reliable and specific data and low prevalence, viewed from a global perspective, we disallow COVID-19 reinfections for modeling purpose to achieve our research objectives. As can be seen in the following sections, this simplification is also mathematically necessary to solve a highly nonlinear multivariate stochastic system empirically.

By construction, the epidemiological identity is preserved by our eSIRD model. With the rapid progression of COVID-19, it suffices to assume an individual must be in one of four said compartments at any time t. With this identity, namely N = S(t) + I(t) + R(t) + D(t), the population infection status follows a closed system with a net zero migration rate:

(5) d S ( t ) d t + d I ( t ) d t + d R ( t ) d t + d D ( t ) d t = 0

It is important to note that our model assumes homogeneity in a given country. This is in contrast to Britton (2020) and Lipton and de Prado (2020), whereas all intra-country heterogeneities such as locality, age or pre-existing condition cohorts, social activities are accounted for. Furthermore, our country-specific homogenous model does not attempt to make any causal inferences or distinguish the evolving COVID-19 virulent nature or the heterogeneous immunity. Although the waves of spread have been incrementally slowed down by varied containment policies, such as travel restriction, face-masking, social distancing, a precise measure of their effectiveness is hampered by inconsistencies both in policies and the actual adherences. It is widely acknowledged that behavior modification is a function of the infection prevalence, thus its standalone impacts are difficult to identify, or found to be statistically insignificant as argued by Atkeson (2021) and Last (2021).

However, the realized transmissibility, as a confluence of these multifaceted and interlinked longitudinal and cross-sectional factors, is ultimately captured effectively by the Reproduction Number ρ(t) following a reduced-form approach in our proposal. The stochastic characteristics prescribed by our model afford a more accurate measurement of pandemic progression transparent to all stakeholders – the general population and the state actors. It allows closer inspections and real-time reading of the interactions between the pathology of viral infection and the uneven human responses notwithstanding the widely available vaccination programs since late 2020. Under this parsimonious setting, we expect that the Reproduction Number vary substantially through the successions of infections, irrespective of endogenous and exogenous causes.

Historical calibration

Modeling epidemics has proved to be a challenging task for researchers. While it is widely known that COVID-19 case data is incomplete and highly imperfect, due largely to the lack of nation-wide rigorous testing and virology monitoring on a continuous basis, the credibility of a historically calibrated model is still primarily judged by the plausibility of epidemiological parameters. This subtlety is consequential, a topic to which we will return in our subsequent discussions.

While COVID-19 is considered to be moderately mutable, within the coronavirus family such as SARS and MERS, there are several invariant properties to which an empirical calibration should adhere. Constrained by the well-defined biomedical definitions of the infection resolution rate γ, and the asymptotic values ( ρ ̄ and m ̄ ) of the CIR processes, valuation with realism and reasonableness should be an overriding priority in determining the optimal model choice and the optimal calibration method.

According to studies from the World Health Organization (WHO) and Johns Hopkins University (JHU), it is a medical fact that the infection resolves within 1–2 weeks for mild symptoms, and up to 6 weeks for the seriously ill. Exploiting the biological information should lead to a superior interpretability and yield a substantial simplification needed for model calibration. We accordingly declare γ as a constant biomedical value. In other words, the COVID-19 infection resolution rate γ is assumed holistically given with a value ranging between 7 and 14 days, independent from model specifications or numerical calibrations.

With γ eliminated from the estimation, the remainder of required eSIR model parameters listed in Table 4 are gathered and collectively referred to as θ:

(6) θ = σ ρ , σ m , κ ρ , κ m , ρ ̄ , m ̄

This global infectious statistics is centrally tracked by government information portals, led by the WHO[3] and the Centers for Disease Control and Prevention (CDC[4]), or by privately-owned data aggregators and research institutions such as JHU.[5] The most followed data are the reported new cases of Infection ∆ C (t), and the daily reported new cases of Death Δ D t : = d D ( t ) .

Following the framework of Equation (3), and using ‘hat’ henceforward to symbolize the estimated latent variables given θ via historical calibration (discussed by the following Section), we can express mathematically the equivalence between the observables and the latent model variables as:

As stated earlier, reinfection disallowance implies that the rate of change in the Susceptible compartment S(t) is strictly negative, and that of the Deceased compartment D(t) is strictly positive. The min and max functions in Equation (7) can therefore be safely removed. In addition, d S ̂ t | θ is replaced by d S t in Equation (7) with the associated direct equivalence, considered as given and independent from parameter assessment.

We further assume that, for COVID-19 pandemic, the initial conditions for all compartments is uniformly disease free across all nations when t = 0. The terminal state and the epidemic equilibrium however, are yet to be determined.

Estimation of the reproduction number and mortality rate

By a discrete-time framework, we can establish a recursive relationship to uncover the empirical realization of I(t) iteratively. By merging the first two lines of Equation (3), the change in the infected population in each time step, dI(t + 1) = I(t + 1) − I(t), is determined by dS(t) and I(t) from the time step prior, with a given γ:

With the initial conditions fixed by Equation (6), and the known dD(t) and dS(t) from Equation (7), the numerical materializations of I(t) and S(t) are attained trivially. After re-arranging our Equation (3), we are now able to present the closed-form expressions of the estimated conditional Reproduction Number ρ(t) and Mortality Rate m(t) as:

Calibration methods

It should be emphasized that ρ ̂ t | γ and m ̂ t | γ are derived based only on the mild assumptions similar to the basic SIR and a medical constant γ. We can thus directly use them as “empirically observed” data as inputs to Equation (4) in searching for the parameter values of θ from a carefully designed stochastic model calibration.

Several contender estimation methods are discussed in what follows, of the salient features of numerical stability, efficiency and plausibility.

  1. The first option in a CIR model calibration is naturally the Maximum Likelihood Estimation (MLE) of the transition density function, given by CIR (1985) explicitly:

    (11) f r s , s | r ( t ) , t = c e u v v u q / 2 I q 2 u v

    where Iq(…) is the modified Bessel function of the first kind of order q, and u, v, q are deterministic functions[6] of model parameters, which are mirrored by the stochastic processes described by Equation (4).

  2. Another MLE approach is to target the residuals { d W ̂ ρ t | γ , θ , d W ̂ M t | γ , θ } revealed by Equation (12), under Gaussian assumptions.

    (12) d W ̂ ρ t | γ , θ = d ρ ̂ t | γ , θ κ ρ ( θ ) ρ ̄ ( θ ) ρ ̂ t | γ , θ d t σ ρ ( θ ) ρ ̂ t | γ , θ d W ̂ m t | γ , θ = d m ̂ t | γ , θ κ m ( θ ) m ̄ ( θ ) m ̂ t | γ , θ d t σ m ( θ ) m ̂ t | γ ( 1 m ̂ ( t | γ )

  3. Alternative numerical schema may also include moment matching of means, and of variances or co-variance,[7] between the observed and the expectations of the model predictions.

  4. A mixture of MLE and moment matching gives a variety of multi-objective functions, Equation(13) lists one set as an example:

    (13) θ * = min θ l o g L f ̂ ρ ( t | θ ) l o g L f ̂ m ( t | θ ) E Δ C ( t ) Δ C ̂ ( t | θ ) 2 E Δ D ( t ) Δ D ̂ ( t | θ ) 2

    The probability function f ̂ ρ t | γ , θ , f ̂ m t | γ , θ can be unconditionally Gaussian as in Method (3), or the conditional contender as in Method (1), closed-form determinable by parameterization set θ. This non-linear optimization algorithm may also be constrained, by adding Feller’s condition and matching the historically observed timing of the peak infection.

  5. Our final results presented in the next section are, however, estimated by the most robust Ordinary Least Square (OLS) regression method, therefore the uncertainties inherent in the design of loss functions and trials of non-linear algorithms used in a constrained optimization are greatly reduced. This is a worthy undertaking because we find that the aforementioned optimization methods suffer greatly from numeric instability which can obfuscate the identification of the impactful risk factors.

Equation (10) demonstrates that the calibration simplification is made possible by re-arranging the derived ρ ̂ t | γ and m ̂ t | γ in Equation (4) into a pseudo OLS form, Yt = b1X1t + b2X2t, expressly as:

(14) Y t ρ : d ρ ̂ t ρ ̂ t = b 1 ρ : κ ρ ρ ̄ X 1 t ρ : d t ρ ̂ t b 2 ρ : κ ρ X 2 t ρ : ρ ̂ t d t + ϵ t ρ : σ ρ d W ρ t Y t m : d m ̂ t m ̂ t = b 1 m : κ m m ̄ X 1 t m : d t m ̂ t b 2 m : κ m X 2 t m : m ̂ t d t + ϵ t m : σ m d W m t

The parameter set θ, from Equation (10), is transparently and algebraically inferred from two linear regression coefficients, denoted as b1 and b2. The diffusion coefficients {σρ, σm} are estimated directly from OLS residuals after scaling by d t . Additional benefits include the usual goodness of OLS fit statistics, including the standard error of parameters and the coefficient of determination R2.

Results and discussions

Since the declaration from WHO identifying COVID-19 as a public health emergency of international concern in January 2020, numerous governmental and healthcare organizations have been mobilized to track the pandemic status. For our country-specific analysis, the raw COVID-19 data is sourced from the Humanitarian Data Exchange (HDX),[8] an open platform for sharing data across crises and organizations. It records the daily new and cumulative numbers of confirmed infection and death in a machine-readable format, for each country across the global. This dataset has been cited by a number of studies of COVID-19 pandemic, Last (2021) and Abbasimehr, Paki, and Bahrini (2021) are counted among the notables.

Data preparation

Given the difficulties in screening and uneven testing capabilities, intermittently changing public health policies and heterogeneous beliefs in every population, the COVID-19 data quality is significantly tainted with delays and extensive inaccuracies. In the presence of widespread noise, we choose to preprocess the raw data and use the smoothened time series instead as model inputs for calibration. Utilizing a Gaussian kernel smoothing algorithm, we can show in Figure 3 a visual comparison of raw data and their smoothened counterparts to illustrate the effects and the operational necessity:

Figure 3: 
Left: COVID-19 cases | Right: COVID-19 deaths. Empirical data (original label) vs. Smoothened data (labeled with prefix ‘s’) of USA.
Figure 3:

Left: COVID-19 cases | Right: COVID-19 deaths. Empirical data (original label) vs. Smoothened data (labeled with prefix ‘s’) of USA.

We then derive the solution Reproduction Number ρ ̂ t | γ and Mortality Rate m ̂ t | γ governed by Equation (10) and graphed in Figure 4:

Figure 4: 
(Purple) Reproduction number 





ρ

̂




t
|
γ




$\hat{\rho }\left(\mathrm{t}\vert \gamma \right)$



 and (Black) mortality rate 





m

̂




t
|
γ




$\hat{m}\left(\mathrm{t}\vert \gamma \right)$



 – USA. Left panel assumes 7 days infection resolution | Right panel assumes 14 days infection resolution.
Figure 4:

(Purple) Reproduction number ρ ̂ t | γ and (Black) mortality rate m ̂ t | γ – USA. Left panel assumes 7 days infection resolution | Right panel assumes 14 days infection resolution.

The estimated Reproduction Number ρ ̂ ( t | γ ) exceeded 10 during the initial acute onset of COVID-19. Shortly after Q2 of 2021, we observed the Reproduction Number dipping below 1 for the first time, resulting from the success of effective vaccine intervention and the efforts and resources invested by the Federal and State-sponsored inoculation programs to the entire US population. This is encouraging as having the Reproduction Number sub 1 is the first indicator of a subsiding infection trend in the population. Since the summer of 2021, however, the Reproduction Number has been fluctuating and moving upward slightly from being over 1 to above 2. There have been several subsequent spikes, with the timing coinciding with the emergence of new variants,[9] holiday seasons and the varied prevalence of unvaccinated people in certain communities. From Alpha, Beta, to more recent Delta and Omicron variants, the unpredictability of COVID-19 mutating path is largely responsible for the recent uptick in transmissibility thus the increasing Reproduction Number.

In a global struggle against COVID-19, the death cases are systematically tracked and the Mortality Rate is studiously monitored to assess the ultimate vulnerability in a population. Unfortunately, the Mortality Rate is also a hard quantity to evaluate with precision. The initial high fatality numbers observed in Figure 4 reflect the rapid succession of COVID-19 outbreaks around the world, which have since moderated substantially. Most epidemiologists and healthcare providers believe that the underestimation of Total Confirmed Infection Cases is widespread, persistent and significant. This is plausible since very limited testing and contact tracing are conducted, developed and emerging market economies notwithstanding. As a result, the empirically estimated Mortality Rate as a ratio of T o t a l C o n fi r m e d D e a t h s T o t a l C o n fi r m e d I n f e c t i o n C a s e s would likely have been overestimated. OurWorldinData[10] has reported the Mortality Rate to highly vary across time and geography, from 14% in Brazil, 6% in US in April-May 2020 to generally below 3% for many countries since 2021. By a different estimation, by taking in a smaller and self-contained sample such as the Diamond Princess cruise-ship outbreak, the Mortality Rate was found to be at around 1–1.5%. We believe our systemically generated m(t) is sufficiently validated by the referenced empirical results.

Guided by the low sensitivity to either 7 day or 14 day infection resolution time range, as demonstrated in Figure 4, we proceed with the subsequent analysis using 14 days fixed period as the COVID-19 resolution parameter γ for all countries.[11]

Calibration result

Obtained by the OLS method discussed in Section 3.2, the numerical values of parameter set θ (as defined by Table 3), are reported in Table 5 along with the statistical significances.

Table 5:

Results of US Model Calibration.

Kρ Km σρ σm ρ m
Value 36.57a 3.18a 4.62a 0.871 1.48a 2.08%a
  1. aSignifies a 99% confidence level.

The results provide a strong support for our proposed eSIR model evident from the significant t-stats for almost all parameters. The coefficient of determination R2 derive by OLS method is 83% for ρ ̂ t | γ , while a much less satisfactory coefficient of 1.4% found for m ̂ t | γ as reported in Appendix D. The transmission half-life for ρ ̂ t | γ , by the standard expression for a mean-reversion process ( log ( 2 ) κ ρ ), is estimated to be about 1 or 2 weeks, not unreasonable length judging by the actual infection waves experienced in the US. The speed at which the fatality rate reverts to mean is however considerably slower by comparison, if κm serves as a rough guide. This particular result at a low statistical significance is nonetheless not unexpected since the onset of COVID-19 was only 2 years ago, and the effective therapeutics is still under active development worldwide.

In contrast to the concluded Ebola (2014) and SARS (2003) outbreaks, the Reproduction Number of COVID-19 has an asymptotic mean ρ ̄ valued to be greater than 1 with a 99% statistical confidence, perhaps a disappointment from earlier hope for eradication. Sustained by varying variants and unvaccinated population, the prospect of COVID migrating from being a pandemic to endemicity is not rejected by the result of our analysis based on the data collected thus far. Factoring in the strength and duration of immune protection from vaccination and natural infection, patterns of human contacts under current social and economic structure, the possibility of COVID-19 to continue circulating is not negligible. Relatedly, the Reproduction Numbers of Smallpox and measles are estimated to be 5–16, and 2–5 of HIV.[12] Should COVID-19 ultimately turn endemic, a case in which the Reproduction Number exceeds and stays above 1, the implications of maintaining a continued containment are profound, as discussed by Brauer et al. (2019).

The onset effects

To evaluate the performance of the regression based calibration, we present Figure 5 in which the residuals of Equation (14), namely ε t ρ and ε t m , are plotted against the timeline and Figure 6 their density distributions. While the onset effects are not statistically insignificant upon inspection, it can also be said that the residuals are concentrated in a small fraction of the duration of the still on-going COVID-19 pandemic.

Figure 5: 
Time series of residuals (Left 




ε


t


ρ




${\varepsilon }_{\text{t}}^{\rho }$



|Right 




ε


t


m




${\varepsilon }_{\text{t}}^{\text{m}}$



) of USA.
Figure 5:

Time series of residuals (Left ε t ρ |Right ε t m ) of USA.

Figure 6: 
Density functions of residuals (Left 




ε


t


ρ




${\varepsilon }_{\text{t}}^{\rho }$



|Right 




ε


t


m




${\varepsilon }_{\text{t}}^{\text{m}}$



) of USA.
Figure 6:

Density functions of residuals (Left ε t ρ |Right ε t m ) of USA.

Early March through July of 2020 was the period during which the world first discovered COVID-19. These single peaks found on Figure 5 correspond to the devastating harm inflicted on an unsuspecting population, marked by mass hospitalizations and shocking number of fatalities. It was only after the acute stage that some stationarity began to incrementally emerge. Helped by voluntarily learned behavior modifications or forced by government mandates, and rapid developments in pharmaceutical intervention measures, the initial unimpeded outbreaks have evolved to become cascading infection surges. We believe these counter-interactive effects have created the necessary condition under which the Brownian motions became admissible. The inherent uncertainties in a protracted pandemic are captured by random walks featured by a stable long-run convergence once a global-scaled equilibrium is reached. However, as informed by the residual analysis, the onset effects of COVID-19 may have negatively impacted the calibration and model efficacy.

As an attempt to bring in the onset effects to the generation of a time-varying Reproduction Number for COVD-19, authors from Linka et al. (2020) propose a hyperbolic tangent function, in a form of ρ t = R 0 1 2 1 + tanh t t * T R 0 ρ t with t* representing the adaptation time or the Onset period and R0 the assumed initial value of the Reproduction Number.

Separately, we have contemplated a time-varying drift term to each of ρ(t) and m(t) processes. Instead of the probabilistic expressions as in Equation (4), let us suppose two deterministic ODE processes as in Equation (15):

(15) d ρ ̃ t = φ ρ t d t = a ρ + b ρ t e λ ρ t d t d m ̃ t = φ m t d t = a m + b m t e λ m t d t

As an example, Figure 7 shows the aforementioned hypothetical onset effects after 2 sets of {a, b, λ} parameters calibrated based on ρ ̂ t | γ and m ̂ t | γ as inputs. Needless to say, the non-linear functional forms of φρ(t) and φm(t) can be more general, and the differential order is not necessarily restricted to 1.

Figure 7: 
Left 





ρ

̂




t
|
γ




$\hat{\mathbf{\rho }}\left(t\vert \gamma \right)$



 (black) and 





ρ

̃




t
|


a


ρ


,


b


ρ


,


λ


ρ






$\tilde {\mathbf{\rho }}\left(\mathrm{t}\vert {\mathrm{a}}_{\rho },{\mathrm{b}}_{\rho },{\lambda }_{\rho }\right)$



 (red) | Right 





m

̂



(

t
|
γ

)



$\hat{\boldsymbol{m}}\left(\mathrm{t}\vert \gamma \right)$



 (black) and 





m

̃




t
|


a


m


,


b


m


,


λ


m






$\tilde {\boldsymbol{m}}\left(\mathrm{t}\vert {\mathrm{a}}_{\text{m}},{\mathrm{b}}_{\text{m}},{\lambda }_{\text{m}}\right)$



 (red) – USA.
Figure 7:

Left ρ ̂ t | γ (black) and ρ ̃ t | a ρ , b ρ , λ ρ (red) | Right m ̂ ( t | γ ) (black) and m ̃ t | a m , b m , λ m (red) – USA.

In a fully integrated model with the onset and saturated random dynamics both captured, conceptually, the targeted random processes of state variable ρ(t) and m(t) should then be thought off as a pair of SDE processes of CIR overlaid with φ ρ t and φ m t drifts. The stochastic Equation (4) conceivably could be revised to:

(4*) d ρ t = φ ρ t + κ ρ ρ ̄ ρ t d t + σ ρ ρ t d W ρ t d m t = φ m t + κ m m ̄ m t d t + σ m m t d W m t

Compared to our proposed model as in Equation (4), adding onset effects has several nontrivial and unintended consequences. With the expansion of parameters, undoubtedly the calibration of Equation (4*) would require a robust numerical optimization algorithm of considerable power, within Method (2), (3) or (4) most likely with reasons discussed in Section 3.2. Short of a rapid convergence required by all countries, we find that the canonical trade-off between a superior model specification and an efficient calibratability is a delicate one, a subject certainly worthy of further study.

We therefore conclude that our eSIRD model, operationalized in its original simplified form, is the optimal proposal, fitting for our intended purpose at the current stage of COVID-19 pandemic, useful to produce reliable and actionable insights.

Country-specific comments

Our case study started with the US and expanded to a total of 205 nation states, representing 90% of all countries with COVID-19 case data ever collected.[13] The goal is to identify risk drivers and effective control measures to reduce transmission and prevent fatality. Observed from the data when transmissibility is concerned, behavioral modifications such as masking and social distancing can be just as potent as medical interventions. In the United States, as a prime example, the high dispersion of personal beliefs toward the public health policies plays a significant role behind the high number of deaths in spite of its superiority in healthcare and pharmaceutical advancements. South Africa and Senegal, on the other hand, have outperformed the expectations thanks in significant part to lessons learned through Ebola and malaria epidemics, and SARS and H1N1 respiratory diseases prior to COVID-19. In addition, strengths in their demographics such as younger population may have also bolstered the immune system which is manifested in their national statistics.

It should be emphasized that proposed method of estimating the country specific Reproduction Number ρ(t) and Mortality Rate m(t) is essentially derived closed-form without calibration, with results immediately interpretable and actionable. See the time serious presentations in Appendix A for sampled countries, allowing transparent information sharing and timely institution of risk-based public health protocols, as well as business decisions in maintaining a functional economy. For example, one can compare the response function of China’s zero-COVID policy vs. Brazil’s more liberal risk tolerance, and the high vaccination status of Israel in a sharp contrast to that of Ethiopia and Syria[14] where low vaccination rates are caused principally by vaccine unavailability. The comparison of mortality rates in Sudan, Peru and Romania to those in Denmark and US underscores the critical need for public healthcare infrastructure and the therapeutics developed for COVID-19.

A global status of COVID-19 transmissibility reflecting the changing virology and population immunity is made visible in real-time as in an interactive World COVID-19 Map in Appendix B, and the fatality rate in Appendix C. This is attributable to the low cost and robust framework in our approach. For the ease of readers, we also provided a pictorial of R2, the coefficient of determination of OLS regression of Equation (14), in a world map in Appendix D. For country-specific Reproduction Number and Mortality Rate, the regression statistics is reported on sampled countries by Appendix E.

Simulation

This robust and efficient regression-based calibration is capable of generating realistic scenarios reflecting the real world COVID-19 empirical data. With the parameter set θ calibrated, we are able to simulate CIR[15] processes of { ρ ̂ t | γ , m ̂ t | γ }, then track the resulting case counts of model simulated { S ̂ t | γ , θ , , R ̂ ( t | γ , θ ) ) }. A single path simulation of the modeled evolutions is graphed in Figure 8 for illustration purpose.

Figure 8: 
Simulated single path {S(t), I(t), R(t)} solution – USA.
Figure 8:

Simulated single path {S(t), I(t), R(t)} solution – USA.

The simulated SIR state variables are then transformed into the observables, i.e. the cumulative cases of infections C ̂ (t) and deaths D ̂ ( t ) . Figure 9 compares the empirical observable with the sampled single path simulation results in the US. Reported 64 million cumulative infection cases (in purple), and over 800,000 deaths (in black) as of January 2022 are in close proximity to the simulated model results.

Figure 9: 
Empirical {


C


$\mathcal{C}$



(t),


D

(

t

)



$\mathcal{D}\left(\mathrm{t}\right)$



} vs. simulated {





C

̂




$\hat{\mathcal{C}}$



(t),





D

̂



(

t

)



$\hat{\mathcal{D}}\left(\mathrm{t}\right)$



} – USA.
Figure 9:

Empirical { C (t), D ( t ) } vs. simulated { C ̂ (t), D ̂ ( t ) } – USA.

One of the benefits of the SDE model is to allow looking ahead and gaining perspectives well into the future through Monte Carlo simulation. As depicted in Figure 10, our eSIRD model can be used to harness future shocks within the framework therefore forecast both infection and fatality.

Figure 10: 
Empirical {


C


$\mathcal{C}$



(t),


D

(

t

)



$\mathcal{D}\left(\mathrm{t}\right)$



} (solid lines) vs. experimental forecasting (dotted lines).
Figure 10:

Empirical { C (t), D ( t ) } (solid lines) vs. experimental forecasting (dotted lines).

Conclusion

In this paper, we apply an enhanced version of the stochastic epidemic model to the current ongoing COVID-19 pandemic. Our model retains its original compartmentality in a SIR structural form, fitted by two latent random variables of the Reproduction Numbers and the Mortality rate to be parameterized in a reduced-form fashion. Illuminated by a medical fact that the resolution time for infected individuals is nominally invariant, we are able to estimate the Reproduction Numbers and Mortality Rate closed-form and in real-time. This simple, effective and interpretable approach is directly and immediately useful for the general public and policy makers who are responsible for health protocols, as well as economic decisions.

Uniquely, our model is capable of capturing the evolution of COVID-19 pathogen and human behavioral and medical responses in each country, corresponding to changing government policy, risk tolerance and the availability of vaccination and medical treatments. The same methodology can be easily applied to regions or cities as a tool for a more granular public health risk management.

The calibration results and discussions presented in the paper are based on in-sample statistical regression. Partitioning the time series into training and forecasting sets could shed additional light into the choice of model specification and method for calibration. Compare to the strong performance in modeling the transmissibility, the stochastic process of Mortality Rate may require improvements. Further work, by incorporating the onset effects while preserving the mean-reverting features observed in the real-world, and effectively and efficiently calibrating a combined process could further improve the model predictability and tractability.


Corresponding author: Hong Sherwin, DCR, Commodity Futures Trading Commission Eastern Region, New York, USA, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: Not applicable.

Appendix A: Historical reproduction number and mortality rate by country

Appendix B: World COVID-19 reproduction number map of Jan-17-2022

Appendix C: World COVID-19 mortality rate map as of Jan-17-2022

Appendix D: R2 of OLS Equation (14) of ρ ̂ t | γ ̂

Appendix E: Model calibration sample results

Reproduction number Mortality rate
Region Country ISO κρ ρ ̄ σρ t-stat (b1) t-stat (b2) R2 κm σm t-stat (b1) t-stat (b2) R2
AMRO Argentina AR 33.26 1.62 2.97 94.55 −19.40 92.3% 3.59 1.91% 1.2682 2.76 −0.55 1.0%
AMRO Brazil BR 35.79 1.51 2.60 108.14 −22.96 94.0% 5.97 3.26% 2.7693 3.16 −0.54 1.3%
EURO Bulgaria BG 36.05 1.49 3.82 73.88 −15.79 88.0% 4.63 2.97% 2.7385 3.58 −0.40 1.7%
AMRO Canada CA 37.62 1.43 4.14 68.40 −14.96 86.3% 14.35 1.89% 2.9683 4.31 −0.92 2.4%
AMRO Colombia CO 34.02 1.58 2.72 103.01 −21.38 93.5% 3.40 2.54% 1.5143 2.84 −0.50 1.1%
AMRO Ecuador EC 37.09 1.45 2.46 113.44 −24.54 94.5% 3.95 4.78% 2.6182 3.36 −0.45 1.5%
EMRO Egypt EG 41.21 1.31 4.14 68.54 −15.64 86.3% 4.25 5.20% 2.5422 4.35 −0.52 2.5%
EURO France FR 37.39 1.44 5.54 51.35 −11.15 78.0% 4.54 2.91% 1.7739 3.24 −0.61 1.4%
EURO Germany DE 39.47 1.36 5.90 48.18 −10.76 75.8% 3.06 1.68% 0.5228 4.66 −1.03 2.8%
AMRO Honduras HN 33.32 1.61 2.87 96.49 −19.89 92.6% 30.93 1.89% 13.6690 2.91 −0.44 1.1%
SEARO India IN 38.11 1.42 4.39 64.85 −14.20 85.0% 8.45 1.82% 2.5376 2.94 −0.62 1.1%
SEARO Indonesia ID 39.15 1.37 3.22 87.23 −19.39 91.1% 28.66 3.58% 13.9004 3.28 −0.55 1.4%
EMRO Iran (Islamic Republic of) IR 42.16 1.29 7.56 37.89 −8.74 65.9% 13.86 3.46% 4.7805 3.80 −0.75 1.9%
EMRO Iraq IQ 40.12 1.35 3.98 71.60 −16.05 87.3% 2.91 1.31% 0.8068 2.96 −0.56 1.2%
EURO Ireland IE 35.68 1.50 3.01 92.45 −19.67 92.0% 14.87 1.09% 4.5242 2.84 −0.48 1.1%
EURO Italy IT 38.83 1.39 7.99 35.71 −7.89 63.2% 7.03 3.55% 2.6505 3.65 −0.70 1.8%
WPRO Japan JP 41.15 1.30 8.90 31.87 −7.21 57.8% 5.84 1.19% 1.3497 3.87 −0.66 2.0%
AMRO Mexico MX 38.24 1.41 2.96 95.39 −20.94 92.5% 2.08 7.59% 2.4603 3.02 −0.33 1.2%
EURO Netherlands NL 37.40 1.44 4.04 70.28 −15.27 86.9% 5.27 1.81% 2.4330 2.95 −0.41 1.2%
EMRO Pakistan PK 38.07 1.41 3.21 87.39 −19.13 91.1% 3.29 1.75% 0.7998 3.68 −0.75 1.8%
AMRO Paraguay PY 29.55 1.81 3.25 85.22 −16.50 90.7% 3.72 2.45% 2.4565 2.95 −0.33 1.2%
AMRO Peru PE 36.16 1.50 3.14 89.93 −19.17 91.6% 4.00 7.49% 4.5440 3.07 −0.34 1.2%
WPRO Philippines PH 36.78 1.46 2.93 95.25 −20.50 92.4% 8.40 2.54% 3.2463 3.06 −0.57 1.2%
EURO Poland PL 35.39 1.50 2.81 97.75 −20.75 92.8% 4.34 2.51% 1.9733 3.05 −0.47 1.2%
EURO Portugal PT 35.80 1.50 2.76 101.38 −21.58 93.3% 4.66 1.04% 1.2449 3.11 −0.53 1.3%
EURO Romania RO 36.49 1.46 3.56 78.42 −16.83 89.2% 6.36 4.17% 4.3454 3.11 −0.42 1.3%
EURO Russian Federation RU 36.12 1.50 2.47 113.68 −24.38 94.6% 0.97 4.23% 0.6761 2.95 −0.32 1.2%
EURO Spain ES 38.14 1.41 5.23 54.27 −11.94 79.9% 29.86 2.34% 10.5494 3.09 −0.61 1.3%
SEARO Sri Lanka LK 34.43 1.55 3.28 84.70 −17.74 90.6% 0.29 3.42% 0.3620 2.87 −0.11 1.1%
EMRO Sudan SD 23.01 2.28 3.27 80.97 −13.92 89.8% 11.60 4.71% 15.7853 2.98 −0.23 1.2%
EURO Turkey TR 34.98 1.54 2.40 115.51 −24.34 94.7% 15.41 1.09% 2.4156 3.15 −0.91 1.3%
EURO Ukraine UA 33.02 1.63 3.22 86.74 −17.81 91.0% 2.36 2.68% 1.1267 2.83 −0.44 1.1%
AMRO United States of America US 36.57 1.48 4.62 61.65 −13.26 83.6% 3.18 2.08% 0.8709 3.23 −0.72 1.4%

References

Abbasimehr, H., R. Paki, and A. Bahrini. 2021. “Improving the Performance of Deep Learning Models Using Statistical Features: The Case Study of COVID-19 Forecasting.” Mathematical Methods in the Applied Sciences special issue: 1–15, https://doi.org/10.1002/mma.7500.Search in Google Scholar PubMed PubMed Central

Andersen, L. B. G., P. Jackel, and C. Kahl. 2010. Simulation of Square-Root Processes. https://doi.org/10.30707/LiB5.1Blackwood Wiley Online Library.Search in Google Scholar

Atkeson, A. G. 2021. “Behavior and the Dynamics of Epidemics.” In NBER Working Paper No. w28760. Also available at https://ssrn.com/abstract=3842735.10.3386/w28760Search in Google Scholar

Atkeson, A., K. Kopecky, and T. Zha. 2020. “Estimating and Forecasting Disease Scenarios for Covid-19 with an Sir Model.” In NBER Working Paper No. w27335.10.3386/w27335Search in Google Scholar

Blackwood, J. C., and L. M. Childs. 2018. “An Introduction to Compartmental Modeling for the Budding Infectious Disease Modeler.” Letters in Biomathematics 5 (1): 195–221. https://doi.org/10.30707/LiB5.1Blackwood.Search in Google Scholar

Brauer, F. 2005. “The Kermack–McKendrick Epidemic Model Revisited.” Mathematical Biosciences 198 (2): 119–31. https://doi.org/10.1016/j.mbs.2005.07.006.Search in Google Scholar PubMed

Brauer, F., C. Castillo-Chavez, and Z. Feng. 2019. “Endemic Disease Models.” Mathematical Models in Epidemiology 69: 63–116.10.1007/978-1-4939-9828-9_3Search in Google Scholar

Britton, T. 2020. A Mathematical Model Reveals the Influence of Population Heterogeneity on Heard Immunity to SARS-CoV-2. PubMed.10.1126/science.abc6810Search in Google Scholar PubMed PubMed Central

Bjørnstad, O. N., B. F. Finkenstädt, and B. T. Grenfell. 2002. “Dynamics of Measles Epidemics: Estimating Scaling of Transmission Rates Using a Time Series SIR Model.” Ecological Monographs 72 (2): 169–84. https://doi.org/10.2307/3100023.Search in Google Scholar

Cox, J. C., J. E. Ingersoll, and S. A. Ross. 1985. “A Theory of the Term Structure of Interest Rates.” Econometrica 53 (2): 385–407. https://doi.org/10.2307/1911242.Search in Google Scholar

Giraldo, J. O., and D. H. Palacio. 2008. “Deterministic SIR (Susceptible-Infected-Removed) Models Applied to Varicella Outbreaks.” Epidemiology and Infection 136 (5): 679–87. https://doi.org/10.1017/S0950268807009260.Search in Google Scholar PubMed PubMed Central

Kermack, W. O., and A. G. McKendrick. 1927. “Contribution to Mathematical Theory of Epidemics.” Proceedings of the Royal Society of London 115 (5): 700–21.10.1098/rspa.1927.0118Search in Google Scholar

Last, M. 2021. “Towards the Global Equilibrium of COVID-19: Statistical Analysis of Country-Level Data.” medRxiv 08 (23): 21262413.10.1101/2021.08.23.21262413Search in Google Scholar

Linka, K., M. Perilinck, and E. Kuhl. 2020. “The Reproduction Number of COVID-19 and its Correlation with Public Health Interventions.” Computational Mechanics 66 (4): 1035–50, https://doi.org/10.1007/s00466-020-01880-8.Search in Google Scholar PubMed PubMed Central

Lipton, A., and M. L. de Prado. 2020. Exit Strategies for COVID-19: An Application of the K-SEIR Model (Presentation Slides). Also available at https://ssrn.com/abstract=3579712.10.2139/ssrn.3579712Search in Google Scholar

Perla, J., J. T. Sargent, J. Stachurski, and C. Rackauskas. 2021. Modeling Shocks in COVID 19 with Stochastic Differntial Equations: QuantEcon. Also available at https://julia.quantecon.org/continuous_time/covid_sde.html.Search in Google Scholar

Saleh, A. E., I. Nour, A. Hanif, A. M. M. Zamzam, and S. M. AlJohani. 2017. “A Pandemic Risk Assessment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Saudi Arabia.” Saudi Journal of Biological Sciences 24 (7): 1631–8. https://doi.org/10.1016/j.sjbs.2017.06.001.Search in Google Scholar PubMed PubMed Central

Received: 2022-03-15
Accepted: 2023-02-27
Published Online: 2023-05-12

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/em-2022-0112/html
Scroll to top button